Meet Aunty, the Queen of high throughput protein stability characterization
Webinar Date/Time: Thu, Feb 13, 2025 11:00 AM EST
Join this webinar to learn how to set up and run an Aunty experiment. Get a walkthrough of Aunty’s data analysis of Tm & Tagg and colloidal stability experiments, and get a peek at the highest resolution stability data you’ve ever seen.
Register Free: https://www.biopharminternational.com/bp_w/meet-aunty
Event Overview:
Testing stability of your proteins and formulations can feel like being buried alive when screening boat loads of candidates and conditions. Most classic tools are either inflexible, one-hit wonders that don’t give the full stability picture or seriously low-throughput, creating major bottlenecks that eat up valuable time you need for everything else you’ve got to get done, like yesterday.
Aunty is the fastest and highest throughput protein stability characterization tool on the planet. Load up to 96 of your samples into its plate and Aunty will power through piles of thermal melting and aggregation experiments at unmatched speeds - reading fluorescence, SLS and DLS of the whole plate every minute of a thermal ramp. Screen gobs of candidates and conditions with as many replicates as you want. Aunty busts out plates of results with unprecedented speed and data resolution.
Join this webinar to see how to set up and run an Aunty experiment. Get a walk-through of Aunty’s data analysis of Tm & Tagg and colloidal stability experiments and get a peek at the highest resolution stability data you’ve ever seen.
Speaker:
Andre Mueller, PhD
Marketing Manager, Biologic Solutions
Unchained Labs
Andre Mueller, PhD, is the Product Manager for Aunty and Honeybun at Unchained Labs supporting the development of new biologic and gene therapy drugs. His expertise covers fluorescence, static light scattering, and dynamic light scattering for biophysical characterization of proteins and viral vectors. His research experience spans from structural biology to plant physiology, and he worked in labs in Germany, Sweden, Denmark, and the USA. Andre earned his PhD at the Carlsberg Laboratory and had a postdoctoral appointment at Stanford University.
Register Free: https://www.biopharminternational.com/bp_w/meet-aunty
Novartis Acquisition of Regulus Therapeutics is Complete
June 25th 2025A key property included in the acquisition is farabursen, an investigational next-generation oligonucleotide targeting the microRNA miR-17 with preferential kidney exposure, intended to treat people with autosomal dominant polycystic kidney disease.
